The Impact of Ischemic Time on the Predictive Value of High-Sensitivity C-Reactive Protein in ST-Segment Elevation Myocardial Infarction Patients Treated by Primary Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

The Impact of Ischemic Time on the Predictive Value of High-Sensitivity C-Reactive Protein in ST-Segment Elevation Myocardial Infarction Patients Treated by Primary Percutaneous Coronary Intervention

Published:2013 Issue:10 Volume:43 Page:664
ISSN:1738-5520
Container-title:Korean Circulation Journal
language:en
Short-container-title:Korean Circ J

Author:

Kim Kyung Hwan¹,Kim Wan¹,Kang Won Yu¹,Hwang Sun Ho¹,Cho Sang Cheol¹,Kim Weon²,Jeong Myung Ho³,

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, Gwangju Veterans Hospital, Gwangju, Korea.

2. Department of Cardiovascular Medicine, Kyung Hee University College of Medicine, Seoul, Korea.

3. Department of Cardiovascular Medicine, Chonnam National College of Medicine, Gwangju, Korea.

Publisher

The Korean Society of Cardiology

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://synapse.koreamed.org/pdf/10.4070/kcj.2013.43.10.664

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Symptom-to-balloon time and risk of ventricular arrhythmias in patients with STEMI undergoing percutaneous coronary intervention: The VERY-STEMI study;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-06

2. Evaluation of C-reactive protein as predictor of adverse prognosis in acute myocardial infarction after percutaneous coronary intervention: A systematic review and meta-analysis from 18,715 individuals;Frontiers in Cardiovascular Medicine;2022-11-16

3. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study;BMC Cardiovascular Disorders;2021-12

4. Prognostic significance of inflammatory biomarkers in diabetic and non-diabetic patients with STEMI, treated with primary percutaneous coronary intervention;Vojnosanitetski pregled;2019

5. Thrombomodulin can predict the incidence of second events in patients with acute coronary syndrome: Single-center, retrospective cohort study;Journal of Cardiology;2018-12